Advertise | About Us | Contact Us

Strategy

At the Institute for OneWorld Health we are pioneering an innovative approach to developing the drugs most needed to treat neglected diseases in the newly industrialising and nonindustrialised world On August the Government of India approved our first drug Paromomycin IM Injection to provide a new treatment for visceral leishmaniasis Paromomyc...

Fulfilling the Promise of China

In recent years emerging markets have been rapidly gaining importance world wide And this is certainly the case with pharmaceuticals The dominance of the US and larger markets remains but as overall growth continues to slowreaching just in emerging markets are stepping up the pace Since their share of global pharmaceutical market growth has risen...

Asia\'s Antibody Market

Realising the potential through strategic alliances

The RD sites of most big pharmaceutical companies are undergoing significant change Historically Big Pharma has focussed on the development of small chemical molecules but in recent times investment has broadened to include the development of large molecule biologics such as therapeutic proteins and monoclonal antibodies The future is biologics...

The Indian Pharmaceutical Industry

Promises and perils

The pharmaceutical industry is a risky business but in some ways the key promises of safety integrity transparency compliance and corporate sustainability have not changed over time The way promises must be delivered however is changing fundamentally Pharmaceutical companies increasingly are relying on others to play key roles in this new system an...

Drug Discovery and Development

An Indian Perspective

Before embarking upon a discussion on the role of Indian pharmaceutical industry in the development of drugs for the world market it might be beneficial to review the dilemma faced by leading pharmaceutical companies of the world Companies like Merck were the darlings of Wall Street as well as the public at large However the scenario started changi...

Drug Discovery and India

A force to reckon with

Global Pharmaceutical Industry is at the crossroads On the one side market demand for novel and better medicines is getting redefined and growing due to demographic economic and epidemiological trends But at the same time pharmaceutical companies are finding it difficult to survive since they are unable to innovate and discover new molecules The pi...

Interview- Innovation

The Key Driver

Where do you think the Asian pharma market stands today against the global market in terms of drug discovery From a global front the US Europe and Japan are still the leaders and they will continue to dominate the drug discovery space in terms of coming out with molecules primarily because they have been in the field of discovering new drugs for...

A New Paradigm for the Indian Pharma Industry

Where do you think the Asian pharma market stands today against the global market in terms of drug discovery The Economists Pharmaceutical Survey The Next Big Thing June mentioned that in the year Chinas and Indias share of global drug development was only This share of the drug development pie is likely to rise dramatically from these

Challenges for Pharmaceutical Sales Forces

Lessons from other Sectors

Sales force the main communication channel of the pharmaceutical industry faces many challenges lower perceived product differentiation great heterogeneity in the needs of customers and the value of customers to the company pressure to find more efficient communication channels restricted physician access tighter regulatory constraints the growing...

Personalised Medicine

End of the Blockbuster?

The pharmaceutical industry appears to be at a nexus of its evolution It has been observed that new drug pipelines are less than adequate to continue its recent rate of growth and offtarget safety issues are causing critical postmarketing failures Added to this global economic pressures may impose greater constraints on drug pricing and the introdu...